doctype html
html
  head
    style.
      .flex-container {
      display: -webkit-flex;
      display: flex;
      -webkit-flex-flow: row wrap;
      flex-flow: row wrap;
      text-align: center;
      }
      .flex-container > * {
      padding: 15px;
      -webkit-flex: 1 100%;
      flex: 1 100%;
      }
      .article {
      text-align: left;
      }
      header {background: black;color:white;}
      footer {background: #aaa;color:white;}
      .nav {background:#eee;}
      .nav ul {
      list-style-type: none;
      padding: 0;
      }
      .nav ul a {
      text-decoration: none;
      }
      @media all and (min-width: 768px) {
      .nav {text-align:left;-webkit-flex: 1 auto;flex:1 auto;-webkit-order:1;order:1;}
      .article {-webkit-flex:5 0px;flex:5 0px;-webkit-order:2;order:2;}
      footer {-webkit-order:3;order:3;}
      }
  body
    .flex-container
      header
        h1 #{dname}
      article.article

        h3 Alternative Names
        p
          b Generic Names:
          |  flecainide (fle-KAY-nide)
        p
          b Brand Names:
          |  Tambocor
        hr

        h3 Uses
        li
          | Treating and preventing various types of irregular heartbeat that can be life threatening
        li
          | Stabilizing the heart rhythm when the heart is beating too fast or in an irregular rhythm
        hr

        h3 Dosage
        li
          b Adult Dose for Ventricular Tachycardia:
          br
          |  Initially 100 mg orally every 12 hours, may be increased 50 mg per day, MAX 400 mg/day
          br
          br
        li
          b Adult Dose for Atrial Fibrillation:
          br
          |  Initially 50 mg orally every 12 hours. may be increased 50 mg per day
          br
          br
        li
          b Adult Dose for Wolff-Parkinson-White Syndrome:
          br
          |  Initially 50 mg orally every 12 hours, may be increased 50 mg per day, MAX 400 mg/day
          br
          br
        li
          b Adult Dose for Paroxysmal Supraventricular Tachycardia
          br
          |  Initially 50 mg orally every 12 hours. may be increased 50 mg per day
          br
          br
        li
          b Pediatric Dose for Supraventricular Tachycardia
          br
          |  <1 month: Initially 2 mg/kg/day orally divided every 12 hours. may be increased 50 mg per day
          br
          |  >1 month: Initially 1 to 3 mg/kg/day orally or 50 to 100 mg/m2/day orally in 3 divided dose
          br
          br
        
        hr
        h3 Side Effects

        b More common:
        li
          |  difficult or labored breathing
        li
          |  dizziness, fainting, or lightheadedness
        li
          |  fast, irregular, pounding, or racing heartbeat or pulse
        li
          |  shortness of breath
        li
          |  tightness in the chest
        li
          |  fast, irregular, pounding, or racing heartbeat or pulse
        li
          |  dizziness, fainting, or lightheadedness
        li
          |  fast, irregular, pounding, or racing heartbeat or pulse
        li
          |  shortness of breath
        li
          |  tightness in the chest
        li
          |  shortness of breath
        li
          |  tightness in the chest
        li
          |  wheezing
        br
        b Less common:
        li
          |  burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
        li
          |  chest pain
        li
          |  fainting
        li
          |  feeling of warmth
        li
          |  fever
        li
          |  increased sweating
        li
          |  partial or slight paralysis
        li
          |  redness of the face, neck, arms, and occasionally, upper chest
        li
          |  shakiness and unsteady walk
        li
          |  shakiness in the legs, arms, hands, or feet
        li
          |  swelling of the feet or lower legs
        li
          |  trembling or shaking of the hands or feet
        li
          |  unsteadiness, trembling, or other problems with muscle control or coordination
        br
        b  Rare
        li
          |  Arm, back, or jaw pain
        li
          |  black, tarry stools
        li
          |  bleeding gums
        li
          |  blood in the urine or stools
        li
          |  blurred vision
        li
          |  chest discomfort
        li
          |  chest tightness or heaviness
        li
          |  chills
        li
          |  confusion
        li
          |  convulsions
        li
          |  cough
        li
          |  decrease in the frequency of urination
        li
          |  decrease in urine volume
        li
          |  difficulty in passing urine (dribbling)
        li
          |  difficulty with breathing
        li
          |  dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
        li
          |  frequent urination
        li
          |  general feeling of discomfort or illness
        li
          |  headache
        li
          |  increased volume of pale, dilute urine
        li
          |  nausea
        li
          |  nervousness
        li
          |  noisy breathing
        li
          |  painful or difficult urination
        li
          |  pinpoint red spots on the skin
        li
          |  pounding in the ears
        li
          |  sensation of pins and needles
        li
          |  slow or fast heartbeat
        li
          |  sore throat
        li
          |  sores, ulcers, or white spots on the lips or in the mouth
        li
          |  stabbing pain
        li
          |  sweating
        li
          |  swollen glands
        li
          |  thickening of bronchial secretions
        li
          |  troubled breathing
        li
          |  unusual bleeding or bruising
        li
          |  unusual tiredness or weakness
        li
          |  yellow eyes or skin

        hr

        h3 Pregnancy
        p
          | Flecainide should only be given during pregnancy when there are no alternatives and benefit outweighs risk.

        hr

        h3 Source
        p
          a(href=link) #{link}
        hr




      footer
        a(href='/search')
          button(type="button", class="btn btn-lg btn-primary btn-block") Back to Search
